Dr. Eduardo de Souza Martins Fernandes, is an esteemed Brazilian surgeon specializing in hepatobiliary surgery, liver transplantation, and abdominal surgical oncology. With a robust educational background, he earned his medical degree from the Faculdade de Medicina de Teresópolis (FESO) in 2001. He then completed his general surgery residency at Rio de Janeiro Adventist Hospital, followed by specialized training in hepatobiliary surgery and transplantation at prestigious institutions such as the Federal University of Rio de Janeiro, the University of Nebraska Medical Center, and Chang Gung Memorial Hospital in Taiwan. Dr. Fernandes further advanced his expertise with a PhD from the Rio de Janeiro State University, focusing on liver transplant techniques.

Currently, Dr. Fernandes holds several key positions. He is the Chief of General Surgery and Transplantation at Rio de Janeiro Adventist Hospital, the Surgical Director of the Liver Transplant Program at DHR Health Transplant Institute in McAllen, Texas, and an Assistant Professor of Surgery at both Rio de Janeiro Federal University and DHR Health. Additionally, he serves as a visiting professor at the Pontifical Catholic University of Chile and Surgical Director at Hospital São Francisco de Assis and Hospital São Lucas, both in Rio de Janeiro. Dr. Fernandes has made significant contributions to international medical conferences, delivering lectures on complex liver resections, transplantation, and pancreatic cancer surgery. He is a respected member of several global surgical societies, including the International Hepatopancreatobiliary Association and the American Hepatopancreatobiliary Association.

Dr. Fernandes' dedication to advancing surgical techniques and improving patient outcomes in transplant and oncology surgery is reflected in his extensive training, leadership roles, and continued participation in international medical education and research.

Dr. Laura Alaimo is a General Surgeon and PhD candidate in Surgical and Cardiovascular Sciences at the University of Verona, Italy, where she holds clinical and surgical privileges in the Unit of General and Hepatobiliary Surgery under the leadership of Prof. Andrea Ruzzenente. Since March 2023, she has been actively involved in both clinical practice and research, contributing to the advancement of hepatobiliary surgery. Her research interests focus on surgical and oncological outcomes in hepatobiliary surgery, with a particular emphasis on the application of machine learning techniques to predict early recurrence of intrahepatic cholangiocarcinoma. Dr. Alaimo's scholarly work has resulted in 98 publications, including 19 as first author, and she has presented her findings at prominent international conferences. Her contributions to the field are recognized through her active participation in academic discussions and her commitment to advancing surgical practices.

Dr. Alaimo is an active member of several esteemed professional societies, including the Italian Society of Surgery (SIC), the Italian Society of Surgical Oncology (SICO), where she is a member of the Liver ONCOTEAM as of 2024, and holds combined membership in the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) and the International Hepato-Pancreato-Biliary Association (IHPBA). She is also affiliated with the Italian Chapter of E-AHPBA (AICEP) and the International Laparoscopic Liver Society (ILLS), reflecting her dedication to the advancement of surgical practices and her commitment to professional development in the field of hepatobiliary surgery.

Trauma surgery; Esophagogastric; Bariatric surgery; Endocrine surgery.